Difference between revisions of "Team:SPSingapore/Safety"
Line 109: | Line 109: | ||
<!----------------------- Entry Start ------------------------> | <!----------------------- Entry Start ------------------------> | ||
<center> | <center> | ||
− | <table style = "width:600px; border-collapse: collapse;text-align:justify;"> | + | <table style = "width:600px; border-collapse: collapse;text-align:justify;font-size:14px;"> |
<tr> | <tr> | ||
<td> | <td> | ||
Line 138: | Line 138: | ||
<br><br> | <br><br> | ||
− | <h3></h3> | + | <h3>Safety Requirements for iGEM Participation</h3> |
− | + | For the fulfillment of requirements for safety from the iGEM foundation, we have submitted the <a href = "https://2015.igem.org/Safety/About_Our_Lab?team_id=1804">‘About our lab’ safety forms</a> and the ‘Final Safety form’. | |
+ | <br><br> | ||
+ | We have also performed a <a href = "https://2015.igem.org/Safety/Check_In">check-in</a> for the <a href = "http://parts.igem.org/wiki/index.php?title=Part:BBa_K299812">Biobricks Part Bba_k299812</a>, which contains the invasin gene from Yersinia pseudotuberculosis and the listerolysin O gene from Listeria monocytogenes. | ||
</td> | </td> | ||
</tr> | </tr> | ||
Line 153: | Line 155: | ||
</div> | </div> | ||
</td></tr></table> | </td></tr></table> | ||
+ | <br><br> | ||
<! ------------------------------- Main Content END ---------------------------------------------> | <! ------------------------------- Main Content END ---------------------------------------------> |
Revision as of 19:26, 12 September 2015
Safety |
|